Læknablaðið - 15.03.2010, Side 41

FRÆÐIGREINAR
SJÚKRATILFELLI OG YFIRLIT
Heimildir
1. Kawasaki A, Purvin V. Giant cell arteritis: an updated review.
Acta Ophthalmologica 2009; 87:13-32.
2. Baldursson O, Steinsson K, Bjomsson J. Giant cell arteritis in
Iceland. Arthritis & rheumatism 1994; 37:1007-12.
3. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia
rheumatica. Ann Intem Med 2003; 139: 505-15.
4. Rahman W, Rahman FZ. Giant cell (temporal) arteritis: an
overview and update. Surv Ophthalmol 2005; 50: 415-28.
5. Miller NR. Visual manifestations of temporal arteritis.
Rheum Clin North Am 2001; 27: 781-97.
6. Font C, Cid MC, Coll-Vinent B, Lopez-Soto A, Grau JM.
Clinical features in patients with permanent visual loss due
to biopsy-proven giant cell arteritis. Br J Rheumatol 1997; 36:
251-54.
7. Miller NR. Epidemiology of giant cell arteritis in an Arab
population: a 22-year study. Br J Ophthalmol 2007; 91: 705-6.
8. Langford CA. Vasculitis in the geriatric population. Clin
Geriatr Med 2006; 21: 631-47.
9. Salvarani C, Fabrizio C, Hunder GC. Polymyalgia rheumatica
and giant-cell arteritis. Lancet 2008; 373: 234-45.
10. Hayreh SS, Zimmerman B. Management of giant cell
arteritis. Ophthalmologica 2003; 217: 239-59.
11. Man PY, Dayan MR. Giant cell arteritis with normal
inflammatory markers. Acta Ophthalmol Scand 2007; 85:460.
12. Schmidt WA. Current diagnosis and treatment of temporal
arteritis. Curr Treat Options Cardiovasc Med 2006; 8:145-51.
13. Guðmundsson A, Helgason S, Guðbjömsson B. Forvamir
og meðferð á beinþynningu af völdum barkstera. Klínískar
leiðbeiningar. Læknablaðið 2002; 88:101-6.
14. Sharma NS, Ooi JL, McGarity BH, Vollmer-Conna U,
McClusky P. The length of superficial temporal artery
biopsies. A NZ Surg 2007; 77: 437-9.
15. Carroll SC, Gaskin BJ, Danesh-Meyer HV. Giant cell arteritis.
Clin Exp Ophthalmol 2006; 34:159-73.
16. Evans JM, O'Fallon WM, Hunder GG. Increased incidence
of aortic aneurysm and dissection in giant cell (temporal)
arteritis. A population-based study. Ann Intem Med 1995;
122: 502-7.
17. Warrington KJ, Matteson EL. Management guidelines and
outcome measures in giant cell arteritis (GCA). Clin Exp
Rheumatol 2007; 25 (Suppl. 47): 137-41.
18. Jonasson F, Cullen JF, Elton RA. Temporal arteritis. A 14-year
epidemiological, clinical and prognostic study. Scott Med J
1979; 24:111-7.
Giant cell arteritis - two cases with acute blindness
Giant cell arteritis is characterized primarily by
inflammation in certain large and medium-sized arteries.
The major risk factors are age, female gender and Northern
European descent.
In this report we describe two cases of acute vision loss
due to giant cell arteritis. In both cases the erythrocyte
sedimentation rate (ESR) was below 50 mm/hr and the
presenting complaint was foggy vision followed by acute
blindness. The cases are to some extent different, for
example in the former case the patient reported jaw
claudication and ophthalmologic evaluation was consistent
with anterior ischemic optic neuropathy. In the latter case
there was narrowing and box-carring of blood cells in
retinal arterioles, consistent with occlusion of the central
retinal artery. This patient had recently finished a 2-year
long treatment with glucocorticosteroids for polymyalgia
rheumatica.
The retina and the optic nerve do not survive for long
without perfusion. If giant cell arteritis causes blindness
in one eye there is significant risk for the other eye to go
blind if no treatment is given. Corticosteroids can spare
the other eye and suppress the underlying infiammatory
disease process as well. It is vital to confirm the diagnosis
of giant cell arteritis with a biopsy and start corticosteroid
treatment as soon as possible, even before the biopsy is
taken.
Elfarsson A, Gudbjomsson B, Stefansson E.
Giant cell arteritis - two cases with acute blindness. Icel Med J 2010; 96: kkkkfff.
Keywords: Giant cell arteritis, Corticosteroids, Headache, Acute blindness, Anterior ischemic optic neuropathy, Central retinal artery
occlusion.
Correspondence: Einar Stefánsson, einarste@landspitali.is
Barst: 18. ágúst 2009, - samþykkt til birtingar: 9. desember 2009
Hagsmunatengsl: Engin
LÆKNAblaðið 2010/96 189
ENGLISH SUMMARY